Pharmaceutical manufacturer Sigachi Industries has announced a 10 per cent final dividend for FY25 after posting a strong Q4 ...

Regeneron Pharmaceuticals (NasdaqGS:REGN) announced favorable Phase 3 trial results for itepekimab and entered a significant licensing agreement with Telesis Bio, enhancing its R&D capabilities.

Research news last week included Rocket Pharmaceuticals suffering a setback with its Phase II trial of RP-A501, which ...

The Hyderabad-based BSE smallcap company's revenue from operations surged by 23 per cent to ₹128.2 crore, compared to ₹104.1 ...

The medium-sized biopharma is showing off new results from dordaviprone and Zepzelca, both of which were acquired through ...

Wells Fargo began coverage on Bio-Techne Corporation (NASDAQ:TECH)’s stock with an “Overweight” rating and a price objective ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) faced a turbulent week as its shares plunged 17%, despite announcing ...

Live maggots outperform traditional surgery in healing chronic wounds. Medical maggot therapy shows faster recovery times and ...

South Korean pharmaceutical and biotech companies are on track to exceed 10 trillion won ($7.5 billion) in licensing revenues ...

Big names in the fashion industry, such as the editorial director of British Vogue, Chioma Nnadi, has previously expressed ...

In a breakthrough for evidence-based wellness, HydrogenWaterBottleCo.shop today unveiled its top-rated Hydrogen Water Bottle. Gary Brecka mentioned the hydrogen water is very beneficial for reducing ...

Mycetoma is endemic in rural Sudan, particularly prevalent in Sennar, Gezira, White Nile, and North Darfur states. The ...